title: Steroids in prostate cancer: the jury is still out... and even more confused.
authors.affiliation: Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy. Electronic address: c.porta@smatteo.pv.it.
authors.forename: Camillo
authors.initials: C
authors.lastname: Porta
authors.affiliation: Medical Oncology, Department of Oncology, San Donato Hospital, Tuscany Tumor Institute (ITT), Arezzo, Italy.
authors.forename: Sergio
authors.initials: S
authors.lastname: Bracarda
authors.affiliation: Clinical Pharmacology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
authors.forename: Romano
authors.initials: R
authors.lastname: Danesi
mesh_terms: D003907:Dexamethasone / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use*; D017430:Prostate-Specific Antigen / Q000097:blood*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*
chemical_list: D003907:Dexamethasone; D011239:Prednisolone; D017430:Prostate-Specific Antigen